ALMR Instruments — Revenue increased by 78.0% to $7.38M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market adoption of the company's hardware platform and expansion of the installed base, while a decrease may signal market saturation, increased competition, or delays in capital equipment procurement by customers.
This metric represents the total revenue recognized from the sale or lease of proprietary proteomics instrumentation sys...
Comparable to 'Instrument Revenue' or 'Systems Revenue' reported by life science tools and diagnostics companies that utilize a razor-and-blade business model.
almr_segment_instruments_revenue_from_contract_with_customer_excluding_assessed_tax| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $4.15M | $7.38M |
| QoQ Change | — | +78.0% |
| YoY Change | — | +78.0% |